REGENERATIVE MEDICINE CONSULTANT Trademark
Trademark Overview
On Thursday, December 21, 2023, a trademark application was filed for REGENERATIVE MEDICINE CONSULTANT with the United States Patent and Trademark Office. The USPTO has given the REGENERATIVE MEDICINE CONSULTANT trademark a serial number of 98326385. The federal status of this trademark filing is PRIORITY ACTION MAILED as of Friday, July 19, 2024. The REGENERATIVE MEDICINE CONSULTANT trademark is filed in the Education & Entertainment Services category with the following description:
Medical training and teaching; Providing training for certification in the field of medical services in the field of human body function restoration and regeneration treatments provided by non-licensed medical professionals
General Information
Serial Number | 98326385 |
Word Mark | REGENERATIVE MEDICINE CONSULTANT |
Filing Date | Thursday, December 21, 2023 |
Status | 658 - PRIORITY ACTION MAILED |
Status Date | Friday, July 19, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Medical training and teaching; Providing training for certification in the field of medical services in the field of human body function restoration and regeneration treatments provided by non-licensed medical professionals |
Classification Information
International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
US Class Codes | 100, 101, 107 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, December 21, 2023 |
Primary Code | 041 |
First Use Anywhere Date | Wednesday, February 1, 2017 |
First Use In Commerce Date | Monday, February 27, 2017 |
Trademark Owner History
Party Name | NOT AVAILABLE |
Party Type | 10 - Original Applicant |
Legal Entity Type | 01 - Individual |
Address | Mesa, AZ 85206 |
Trademark Events
Event Date | Event Description |
Thursday, December 21, 2023 | NEW APPLICATION ENTERED |
Wednesday, April 3, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, July 16, 2024 | ASSIGNED TO EXAMINER |
Friday, July 19, 2024 | PRIORITY ACTION E-MAILED |
Friday, July 19, 2024 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
Friday, July 19, 2024 | PRIORITY ACTION WRITTEN |